SCHEMBL17657299

SCHEMBL17657299

C=Cc1cccc2oc(CC)c(-c3ccccc3)c(=O)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.36
▸ PTGS1 P23219 1/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CYP2C9 P11712 6/20 0.34
▸ TP53 P04637 3/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ HPGD P15428 3/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31395666 0.81 MAPT (0.39) MAPTPTGS1PTGS2CA1CA2
SCHEMBL17718332 0.80 TTR (0.44) MAPTPTGS1PTGS2CA1CA2
SCHEMBL13717954 0.80 AR (0.48) MAPTPTGS1PTGS2CA1CA2
SCHEMBL17657298 0.80 TTR (0.36) MAPTCYP2C9HPGDHSD17B10MEN1
SCHEMBL17657308 0.77 MEN1 (0.34) MAPTCA1CA2TP53KDM4E
SCHEMBL8733 0.76 CA1 (0.59) MAPTCA1CA2CYP2C9TP53
SCHEMBL13545619 0.75 MAPT (0.54) MAPTPTGS1PTGS2CA1CA2
SCHEMBL17657286 0.72 LMNA (0.34) MEN1KMT2ALMNAUSP2HSP90AA1
SCHEMBL9078888 0.71 CYP3A4 (0.67) MAPTCA1CA2CYP2C9TP53
SCHEMBL18709047 0.70 ALDH1A1 (0.39) MAPTPTGS1PTGS2CYP2C9TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016054491-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2016-04-07 — — WO disclosed
Send feedback